Media formats available:
Recommended
James Januzzi, MD
Erik Stroes, MD, PhD
- ACC.24
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Alexander J. Blood, MD
Steven Nissen, MD
James Januzzi, MD
Erik Stroes, MD, PhD
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Alexander J. Blood, MD
Steven Nissen, MD